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The chicken ovalbumin upstream promoter-transcription
factors (COUP-TFs) are “orphan” members of the nuclear hor-
mone receptor (NR) superfamily. COUP-TFs are involved in
organogenesis and neurogenesis. However, their role in skeletal
muscle (and other major mass tissues) and metabolism remains
obscure. Skeletal muscle accounts for40% of total body mass
and energy expenditure. Moreover, this peripheral tissue is a
primary site of glucose and fatty acid utilization. We utilize
small interfering RNA (siRNA)-mediated attenuation of Coup-
TfI and II (mRNA and protein) in a skeletal muscle cell culture
model to understand the regulatory role of Coup-Tfs in this
energy demanding tissue. This targeted NR repression resulted
in the significant attenuation of genes that regulate lipid mobi-
lization and utilization (including Ppar, Fabp3, and Cpt-1).
This was coupled to reduced fatty acid -oxidation. Addition-
allyweobserved significant attenuationofUcp1, a gene involved
in energy expenditure. Concordantly, we observed a 5-fold
increase in ATP levels in cells with siRNA-mediated repression
of Coup-TfI and II. Furthermore, the expression of “classical”
liver X receptor (LXR) target genes involved in reverse choles-
terol transport (Abca1 and Abcg1) were both significantly
repressed.Moreover, we observed that repression of theCoup-Tfs
ablated the activation of Abca1, and Abcg1 mRNA expression by
the selective LXR agonist, T0901317. In concordance, Coup-Tf-
siRNA-transfectedcellswere refractory toLxr-mediatedreduction
of total intracellular cholesterol levels in contrast to the negative
control cells. In agreement Lxr-mediated activation of the Abca1
promoter in Coup-Tf-siRNA cells was attenuated. Collectively,
these data suggest a pivotal role for Coup-Tfs in the regulation of
lipid utilization/cholesterol homeostasis in skeletal muscle cells
and themodulation of Lxr-dependent gene regulation.
Nuclear receptors (NRs)3 comprise a large family of DNA-
binding transcription factors that control many cellular and
physiological processes crucial for development and survival.
Dysregulation of nuclear receptor signaling leads to prolifera-
tive, reproductive, and metabolic disorders such as cancer,
infertility, dyslipidemia, and insulin resistance/type II diabetes
(1). Consequently, NRs are a major focal point of intense clini-
cal and pharmaceutical studies. The NR superfamily includes
receptors for steroid hormones, vitamin D, ecdysone, retinoic
acids (all-trans and 9-cis isoforms), and thyroid hormones. In
addition to these known receptors for known ligands, there are
a number of NRs to which no ligand has been described, and
thus, designated “orphan” receptors.
Of the orphan nuclear receptors, the chicken ovalbumin
upstream promoter-transcription factors (COUP-TFs) have
received considerable attention for their role in neurogenesis,
organogenesis, and embryogenesis (2–4). In mouse there are
two highly relatedCoup-Tfs (Coup-TfI andCoup-TfII) encoded
by distinct genes on chromosomes 13 and 7, respectively (5).
Interestingly, Coup-Tfs can modulate the activity of genes that
are fundamental in the orchestration of glucose and lipid
metabolism. These include, bile acid synthesis (Cyp7A-
cholesterol 7-hydroxylase) (6), ketogenesis (mitochondrial
hydroxymethylglutaryl-CoA synthase) (7), cholesterol trans-
port (cholesterol ester transfer protein and apolipoprotein AI)
(8, 9), and fatty acid -oxidation (medium-chain acyl-coen-
zyme A dehydrogenase) (10). Furthermore, organ-specific
(pancreatic  cells) Coup-TfII null mutants in mice demon-
strated a role for Coup-Tf in glucose homeostasis and insulin
sensitivity (11). In addition, theCoup-Tf ortholog inDrosophila
(seven up) is required for the expression of alcohol dehydrogen-
ase and type IV collagen, two genes that are essential for fat cell
differentiation (12). Although Coup-Tfs are implicated in
metabolism in these systems, little is known of the role of these
NRs with respect to metabolism in skeletal muscle, and other
major mass peripheral tissues.
Skeletalmuscle is one of themostmetabolically active tissues
in the body that accounts for30% of total energy expenditure.
By virtue of its large mass (40% of body weight) and signifi-
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cant energy demands, skeletalmuscle provides a vital milieu for
fatty acid and glucose homeostasis (13). Furthermore, it is also
involved in cholesterol efflux (i.e. reverse cholesterol transport)
(14). Consequently, skeletal muscle plays a considerable role in
insulin sensitivity and the blood lipid profile. These character-
istics alone suggest that skeletal muscle has an integral role in
metabolism and provides an attractive target tissue to study the
role of orphan nuclear receptors with respect to metabolism in
this system.
Previous studies from this laboratory have identified a role
for the orphan nuclear receptors (including Ror, Rev-erb,
and Nur77) in the regulation of the genetic programs control-
ling lipid homeostasis in the mouse C2C12 skeletal muscle cell
line (15–17). Moreover, other studies have successfully utilized
this model system to studyCoup-Tfs. For example, constitutive
expression of Coup-TfI repressed the activity of the human
muscle glycogen phosphorylase gene promoter in C2C12s (18).
In fact, theC2C12 cell line has been used to study the functional
role of many orphan nuclear receptors (14). The ability of this
cell line to differentiate into multinucleated fibers in tissue cul-
ture (19), coupled to the acquisition of a contractile and meta-
bolic phenotype, provides a robust system to study the role of
COUP-TF in skeletal muscle metabolism.
In this study we tested the hypothesis that Coup-Tfs are
implicated in the regulation of pathways controlling metabo-
lism. Our studies suggest a role for Coup-Tfs in (i) the modula-
tion of key genes involved in lipid utilization (Ucp1, Ucp3,
Fabp3, and Cpt-1) and (ii) the regulation of total cholesterol
levels, and liver X receptor (Lxr)-dependent expression of the
ATP-binding cassette proteins that control cholesterol efflux
(Abca1 andAbcg1). The role ofCoup-Tfs in this systempresents
an essential platform to further study lipid utilization and cho-
lesterol efflux in skeletal muscle. Importantly, these processes
have implications for disease states such as dyslipidemia.
MATERIALS ANDMETHODS
Cell Culture—Proliferating mouse C2C12 myoblasts were
cultured andmaintained in DMEM (Invitrogen) supplemented
with 10% heat-inactivated Serum Supreme (Cambrex Bio Sci-
ence, Victoria, Australia). Differentiation of myoblasts into
post-mitotic, multi-nucleated myotubes was induced by mito-
gen withdrawal, i.e. DMEM supplemented with 2% horse se-
rum (differentiation medium, DM) (Trace, Scientific, Victoria,
Australia) for 4 days.
RNA Extraction and cDNA Synthesis—Total RNA was
extracted fromC2C12 cells using TRI-Reagent (Sigma) accord-
ing to themanufacturer’s protocol. Total RNAwas then treated
with 2 units of TurboDNase I (Ambion, Austin, TX) for 30min
at 37 °C followed by purification of the RNA through anRNeasy
purification column system (Qiagen, Victoria, Australia). RNA
was electrophoresed to determine the integrity of the prepara-
tion. SuperScript III was used to synthesize cDNA from 4 g of
total RNA using random hexamers according to the manufac-
turer’s instructions (Invitrogen). The cDNAwas then diluted to
300 l in nuclease-free water.
Protein Extraction—Total soluble protein was extracted
fromC2C12 cells by the addition of lysis buffer (10mMTris, pH
8.0, 150 mM NaCl, 1% Triton X-100, 5 mM EDTA) containing
protease “mixture” inhibitors (Sigma). Lysates were passed
through a 26-gauge needle and centrifuged at 10,000 g for 20
min. The supernatant was collected and total protein concen-
tration was determined by the BCA as outlined by the manu-
facturer’s instructions (Pierce).
Generation of Coup-TfI-siRNA Construct—A 21-mer siRNA
duplex specific to the annotated mouse cDNA sequence of
Coup-TfI (NM_010151) was generated with the siRNA target
finder from Ambion. The target sequence, Coup-TfI-5-AAG-
CACTACGGCCAATTCACC-3, was chosen based on having
no sequence similarity with other members of the nuclear
receptor family and low sequence homology with non-target
murine sequences. The sense and antisense siRNA oligomers
were synthesized (Geneworks, SA, Australia) and cloned into
the pSilencer 3.1 neomycin vector as described by themanufac-
turer (Ambion). Target sequences were confirmed by direct
sequencing at the Australian Genome Research Facility, Uni-
versity of Queensland, Brisbane, Australia.
Transient Transfections of siRNA Constructs—C2C12 myo-
blasts were grown to80% confluence and three independent
transfections of Coup-TfI (4 g/10-cm dish) and the pSilencer
3.1 negative control siRNA sequence (a sequence not found in
the rat, human, or the mouse genome, Ambion) were per-
formed in the presence of Lipofectamine 2000 as outlined by
the manufacturer’s protocol (Invitrogen). Twenty-four h post-
transfection, fresh DM was added for a further 24 h and RNA
was collected as outlined above.
Generation of C12C2 Stable Coup-Tf-siRNA Cell Lines—
C2C12 cells were transfected at 50% confluence with 4 g of
pSilencer-3.1-Coup-Tf and 4 g of pSilencer-3.1-negative con-
trol in 2 HEPES, 10 l of N-[1(2,3-dioleoyloxy)propyl]-
N,N,N-trimethylammonium salt (DOTAP), and 10 l of Meta-
fectene (Scientifix, Victoria, Australia) per 25-cm2 flask. Cells
were subsequently passaged into 10-cm2 round flasks followed
by 8–12 days selection with 700 g/ml G418 in DMEM. Fol-
lowing the selection process and the death of the non-trans-
fected control population, viable siRNA-transfectant stable cell
populations were maintained in DMEM supplemented with
300 g/ml G418. The large number of stable transfectants
(100 colonies) were passaged into three independent poly-
clonal pools (to avoid clonal bias) and independently, passaged,
cultured, and propagated for various experiments. Each inde-
pendent stable myoblasts were then differentiated into myo-
tubes as outlined above.Myoblasts and differentiatedmyotubes
were analyzed on aNikon Eclipse TS100microscope (Coherent
Scientific, SA, Australia) and digital images were captured on a
Nikon Coolpix 4500 digital camera.
T0901317Treatment of StableC2C12Cell Lines—C2C12 cell
lines stably expressing the pSilencer negative 3.1 control and
the Coup-Tf-siRNA were grown to confluence and then
induced to differentiate over a 4-day period. At day 3 of differ-
entiation, the cells were treated with either vehicle (Me2SO) or
LXR agonist, T0901317 (10 M), until day 4 of differentiation.
The cells were then collected for RNA processing as outlined
above.
Quantitative Real-time PCR (Q-RT-PCR)—Q-RT-PCR was
performed on an ABI Prism 7500 sequence detection system
(Applied Biosystems) in triplicate on three independent RNA
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preparations. Target cDNA levels were analyzed in 25-l reac-
tions with either SYBR Green or TaqMan Technologies
(Applied Biosystems). Primers (200 nM) used for the amplifica-
tion of target gene sequences have been described in detail (15–
17). PCR was performed with 5 l of cDNA and 45 cycles of
95 °C for 15 s and 60 °C for 1 min. The relative level of target
gene expression was normalized to Gapdh or 18 S ribosomal
RNA as described under “Results” and associated errors were
calculated using the guidelines described by Bookout andMan-
gelsdorf, on the Nuclear Receptor Signaling Atlas website
(NURSA). Statistical analysis was performed on the average of
three independent assays and a Student’s t test was performed
to calculate significance.
Western Blot Analysis—Total soluble protein from the
pSilencer 3.1 negative control and pSilencer 3.1 Coup-TfI-
siRNA stable C2C12 cell lines was resolved on a 10% SDS-
PAGE gel and transferred to a nitrocellulose membrane. The
membranes were blocked overnight or for 1 h in 5% skim milk
in Tris-buffered saline/Tween 20 followed by an overnight
incubation with either Coup-TfI (1:3000, sc-6577), Coup-TfII
(1:2000, sc-5578), Abca1 (1:1000, sc-20794) (Santa Cruz
Biotechnology, Inc.), or Gapdh (1:10,000) (R&D Systems,
Minneapolis, MN) antibodies. Following 4  15-min washes
the membrane was incubated with either anti-goat horseradish
peroxidase (Coup-TfI and II) or anti-rabbit horseradish perox-
idase (Gapdh and Abca1) (1:2000) for 1 h. Immunoreactive sig-
nals were detected using enhanced chemiluminescence Super-
Signal West Pico Substrate (Pierce) and visualized by
autoradiography on an X-Omat film developer (Kodak).
Luciferase Assay—C2C12 stable Coup-Tf-siRNA and the
negative 3.1 control cells were grown in DMEM in 24-well
plates to 80% confluency. Transient transfection of the
ABCA1-Luc promoter (20) (0.5 g/well) was performed in the
presence of Lipofectamine 2000 (Invitrogen). Twenty-four
hours post-transfection, the cells were treated with either vehi-
cle (Me2SO) or LXR agonist, T0901317 (10 M). Luciferase
assays were performed using the LucLite luminescence
reporter gene assay system as outlined by the manufacturer
(PerkinElmer Life Sciences). Luminescence was recorded on a
MicroBeta luciferase system (PerkinElmer Life Sciences) (20).
ATP Assay—A total of 10,000 C2C12 cells (counted by
microscopy via the trypan blue exclusionmethod) per well (96-
well plate) expressing the pSilencer 3.1 negative control and
Coup-Tf-siRNA were seeded and maintained in DMEM. At
100% confluence, DM was added and the cells were induced to
differentiate for 4 days. The measurement of ATP was per-
formed using the ATPlite luminescence ATP detection assay
system as outlined by the manufacturer (PerkinElmer Life Sci-
ences). The results obtained are from three independent poly-
clonal pools, assayed in triplicate. ATP concentration was nor-
malized to total soluble protein. A Student’s t test was
performed to calculate statistical significance.
Amplex Red Cholesterol Assay—The assay for free choles-
terol and cholesterol esters was performed as described by the
manufacturer’s instructions (Invitrogen). Briefly, cell samples
containing the pSilencer 3.1 negative control and the Coup-Tf-
siRNAC2C12 stable cells were seeded at10,000 cells per well
(96-well plate). The cells were thenmaintained in DMEM until
confluent and differentiated in 10% charcoal-stripped DMEM
prior to the addition of 10 mol/liter of the LXR agonist,
T0901317 for 24 h. The cells were then resuspended in Amplex
Red reaction buffer (Invitrogen) and incubated at 100 °C for 30
min to inactivate endogenous cellular cholesterol esterase. Fol-
lowing a 30-min incubation at 37 °Cwith the Amplex Red assay
reagents, fluorescence wasmeasured at an excitation of 530 nm
and emission of 590 nm. The results obtained are from three
independent polyclonal pools, assayed in triplicate. Choles-
terol concentration was normalized to total soluble protein
and a Student’s t test was performed to calculate statistical
significance.
[9,10-3H]Palmitic Acid Assay—The oxidation of [9,10-
3H]palmitate was measured on the basis of 3H2O released into
the cell culture media. Coup-Tf-siRNA stable C2C12 cells were
differentiated in 6-well plates for 4 days in DM. Following dif-
ferentiation, the stable Coup-Tf-siRNA cells were serum-
starved for 4 h and then incubated in 1 ml of fatty acid media
(-minimal essential medium, 2% fatty acid-free bovine se-
rum albumin (w:v), 0.25 mmol/liter palmitate, 1 Ci/ml of
[3H]palmitate, pre-gassed) for 2 h at 37 °C. A total of 250 l of
media was mixed with 1.25 ml of CHC13:MeOH (2:1) for 15
min followed by the addition of 500 l of 2 mol/liter KCl, 2
mol/liter HCl and furthermixed for 15min followed by centrif-
ugation at 2500  g for 15 min. 200 l of the aqueous phase
was removed and mixed with 1.8 ml of scintillation fluid to use
for  counting on a MicroBeta luciferase system (PerkinElmer
Life Sciences). Data were expressed as  S.E. and significance
was calculated using a Student’s t test.
RESULTS
TheCoup-TfI and IImRNAandProteinAre Expressed during
SkeletalMuscle Differentiation—To elucidate the role ofCoup-
TfI and II in skeletal muscle with respect to metabolism, we
initially investigated the expression profile of both Coup-TfI
and IImRNA relative to Gapdh in the mouse C2C12 myoblast
cell line. Proliferating myoblasts can be induced to biochemi-
cally and morphologically differentiate into post-mitotic
multinucleated myotubes by mitogen withdrawal over a
24–96-h period. This transition from a non-muscle to a con-
tractile phenotype is associated with activation and repression
of a structurally diverse group of genes responsible for contrac-
tion and the extreme metabolic demands placed on this tissue.
During this period of differentiation, we observed by Q-RT-
PCR that both Coup-TfI and II mRNA were expressed during
skeletal muscle cell differentiation (Fig. 1, a and b). To assess
the levels of Coup-TfI and Coup-TfII proteins during differen-
tiation we performed Western blotting analysis. High levels of
immunoreactive Coup-TfI and II were observed in the prolif-
erating myoblasts and confluent myoblasts and down-regu-
lated (relative to Gapdh) during myogenesis (Fig. 1, a and b).
To assess the differentiation status of the C2C12 cells and
demonstrate that they had acquired a muscle-specific, con-
tractile and metabolic phenotype, Q-RT-PCR was performed
on several important marker genes encoding myogenin, a gene
that encodes the hierarchical basic helix loop regulator and is
specifically required for differentiation (21), the slow twitch
(type I) and the fast twitch (type II) isoforms of the contractile
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protein troponin I, and the metabolic genes Abca1 and Abcg1
(ATP-binding cassette proteins), Fabp3 (fatty acid-binding
protein 3), Cpt-1 (carnitine palmitoyltransferase 1), and Ucp3
(uncoupling protein 3).
Both the marker of differentiation (myogenin) and the con-
tractile protein genes (types I and II, Tnni1 and Tnni2, respec-
tively) were dramatically induced during the myogenic process
and thus confirmed the differentiated state of the C2C12 cell
(Fig. 2, a–c). Furthermore, the expression of these key myo-
genic markers of differentiation are entirely consistent with
previous studies (15, 17, 22). Additionally, genes involved in
lipid metabolism (Abca1, Abcg1, Cpt-1, and Fabp3) and energy
expenditure (Ucp3) were all induced during skeletal myogen-
esis, and confirmed that the muscle cells had acquired a meta-
bolic phenotype (Fig. 2, d–h). Due to the availability of antibod-
ies against Abca1, we assessed the levels of this protein across
the developmental time course. From these data, the Abca1
protein correlated with the Abca1mRNA profile (Fig. 2d).
Coup-Tf-siRNA Expression Represses Endogenous Levels of
Coup-TfI and Coup-TfII mRNA and Protein in Skeletal Muscle
Cells—To elucidate the biological role of Coup-Tfs in skeletal
muscle with respect to lipid utilization, we preceded to selec-
tively ablate the expression of Coup-TfI and II. RNA interfer-
ence was utilized to create stable cell lines expressing Coup-
Tf-siRNA (having no sequence similarity to other nuclear
receptors) in an attempt to attenuate mRNA levels of both
Coup-TfI and II. As a control we produced stable C2C12 cells
expressing the pSilencer 3.1 negative control (a sequence not
found in the mouse, rat, or human genome). Accordingly, trip-
licate polyclonal C2C12 cell lines stably expressing the pSi-
lencer 3.1 negative control siRNA (negative control) and the
specific COUP-TF-siRNA (Fig. 3a) were subsequently differen-
tiated for 4 days and total RNA and soluble protein was
extracted. Representative images of the C2C12 myoblasts and
myotubes are shown for the negative 3.1 control and the Coup-
Tf-siRNA cells. Both negative 3.1 controls and the Coup-Tf-
siRNA stable cell lines differentiated from a proliferating
mononucleated phenotype to a post-mitotic multinucleated
morphology indicative of a contractile phenotype (Fig. 3b).
Quantitative RT-PCR was then performed to measure the
expression of both Coup-TfI and Coup-TfIImRNA normalized
to both Gapdh and 18 S rRNA in the RNA isolated from the
differentiated negative control and Coup-Tf-siRNA-trans-
fected stable cell lines.We observed a significant attenuation of
both the Coup-TfI (5.0-fold, p  0.0001) and Coup-TfII (4.75-
fold, p 0.0001) mRNA when compared with the negative 3.1
control and normalized to Gapdh (Fig. 3, c and d). Moreover,
the relative expression of Coup-TfI and II mRNA was similar
when normalized to 18 S rRNA (Coup-TfI, 5.65-fold, p 
0.0170, and Coup-TfII, 4.38-fold, p  0.0114) (Fig. 3, c and d).
To determine that the attenuation of both Coup-TfI and II
mRNA was not due to differential Gapdh mRNA expression,
Q-RT-PCR was also performed on Gapdh mRNA normalized
to 18 S rRNA. No change was observed in the levels of Gapdh
mRNA expression in the negative control relative to the Coup-
Tf-siRNA cell lines and thus, validated the attenuated expres-
sion of Coup-TfI and II mRNA in the C2C12 Coup-Tf-siRNA
stable lines (Fig. 3e).
To determine whether the repression ofCoup-TfI andCoup-
TfII mRNA expression also correlated with Coup-Tf protein
levels, Western blot analysis was performed using specific
Coup-TfI and II antibodies. Western blot analysis also con-
firmed both Coup-TfI and II proteins were dramatically
reduced in the C2C12 Coup-Tf-siRNA stables relative to the
negative 3.1 control (Fig. 3, f and g). The effects of Coup-Tf
attenuation by the specific siRNA (relative to the negative 3.1
FIGURE1.ExpressionofCoup-TfIand IImRNAandproteinduring skeletal
muscle differentiation in C2C12 myoblasts and differentiated myo-
tubes. Total RNA and soluble protein from proliferating myoblasts (PMBs),
confluentmyoblasts (CMBs), and 4–144 h of differentiationwere analyzed by
Q-RT-PCR and Western blot analysis. a and b, Q-RT-PCR (top panels) and pro-
tein analysis (lower panels) of Coup-TfI and Coup-TfII, respectively. Gapdh pro-
tein was used as a loading control.
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control) were further validated by analyzing the expression of
both Coup-TfI and II mRNA after transient transfection of the
Coup-Tf-siRNA.C2C12cellswere transiently transfectedwith the
negative 3.1 control andCoup-Tf-siRNA and the endogenous lev-
els of both Coup-TfI and IImRNA were measured in Q-RT-PCR
experiments. BothCoup-TfI and IImRNAwere clearly attenuated
in theCoup-Tf-siRNA transfection (Fig. 3h).Moreover, these data
show that the attenuation of bothCoup-TfI and II is not a result of
the G418 selection process for the generation of stable cell lines,
and is specific to the expression of the siRNA.
Expression of Coup-Tf-siRNA Modulates the Expression of
Genes Involved in Lipid Utilization—Genes involved in lipid
utilization (from intramyocellular lipid depots) and catabolism,
respectively, for example, Fabp3 and Cpt-1) were dramatically
attenuated (14-fold, p  0.0211 and 10.5-fold, p  0.0199,
respectively) (Fig. 4, a and b). Consequently, we examined
whether these changes in gene expression had functional con-
sequences on lipid oxidation in these cells utilizing a 3H2O-
based palmitate assay. In concordance with the dramatic atten-
uation of Cpt-1, we observed reduced fatty acid  oxidation in
the Coup-Tf-siRNA (relative to the negative control) trans-
fected cells (Fig. 4c). A number of other genes important in fatty
acid homeostasis were analyzed (Table 1), however, minimal
nonspecific changes were observed between the negative con-
trol and the Coup-Tf-siRNA cells.
We next analyzed a number of important nuclear receptors
that are modulators of lipid metabolism and homeostasis, for
example, Ppars, Lxr, Lxr, Ror, Err, and Rev-erb (14).
From these studies, we observed a dramatic repression ofPpar
(master regulator of lipid catabolism) mRNA of up to 30-fold
(p  0.0001) in the Coup-Tf-siRNA cells (Fig. 4d). Moreover,
the specificity of Ppar attenuation was supported by the min-
imal changes observed in the expression of the other nuclear
receptors in the Coup-Tf-siRNA-transfected cells (Table 2).
FIGURE 2. Expression ofmarkers indicative of the acquisition of themuscle-specific (myogenin), contractile (Tnni1 and Tnni2), andmetabolic pheno-
types (Abca1, Abcg1, Cpt-1, Fabp3, and Ucp3) during differentiation. a–h, Q-RT-PCR mRNA expression of myogenin, Tnni1, Tnni2, Abca1, Abcg1, Cpt-1,
Fabp3, and Ucp3, respectively. Data are expressed as the mean of triplicate samples  S.D. d, Western blot analysis showing protein levels of Abca1. PMB,
proliferating myoblasts; CMB, confluent myoblasts.
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The myogenic cytokine, Il-15 (Fig. 4e) was down-regu-
lated 5.6-fold (p  0.0084). Il-15 has been demonstrated to
function in a muscle to fat endocrine axis to modulate fat:
lean body composition and insulin sensitivity (23). We also
observed a dramatic attenuation of phosphoenolpyruvate
carboxykinase (Pepck-1) a gene involved in gluconeogenesis.
Pepck-1 was undetectable in Coup-Tf-siRNA cells (Fig. 4f ).
Other genes involved in inflammation and glucose homeo-
stasis were analyzed; however, minimal changes were
observed (Tables 1 and 2).
TheAttenuation of Coup-TfI and II ExpressionModulates the
Expression of the Uncoupling Genes and Steady State ATP
Levels—Subsequently, we analyzed the mRNAs encoding the
uncoupling proteins (Ucp1–3) and other genes (Ampk,,)
involved in energy expenditure, and balance. For example, the
expression of genes encodingUcp1 andUcp3 that are involved
in energy uncoupling and preferential lipid utilization, respec-
tively, were significantly modulated. Specifically, Ucp1 mRNA
was dramatically repressed (and undetectable), whereas in con-
trast, Ucp3 mRNA expression was induced 6.24-fold (p 
0.0024) in the C2C12 Coup-Tf-siRNA cell line (Fig. 5, a and b).
Ucp2 and other genes involved in energy expenditure and bal-
ance were not substantially modulated or significantly changed
in this system (Table 1). To assess the effect of the dramatic
attenuation of Ucp1mRNA in the Coup-Tf-siRNA C2C12 sta-
ble cell lines, we measured and compared the levels of ATP in
the negative control and Coup-Tf-siRNA-transfected C2C12
cells. In concordance with the striking reduction of Ucp1
mRNA expression in the Coup-Tf-siRNA stable cells, we
observed an approximate 5-fold increase in ATP levels in the
FIGURE 3. Transfection of the Coup-Tf-siRNA attenuates Coup-TfI and II mRNA and protein expression. a, schematic representation of the Coup-Tf
receptor and position of the Coup-Tf-siRNA target sequence. The Coup-Tf-siRNA target sequence is shown between amino acids 97 and 103 in the C region of
the DNA-binding domain (DBD). The othermotifs represent the trans-activating domain (A/B), the hinge region (H), and the ligand-binding domain (LBD, E/F).
Note: the sequence above was designed to target the Coup-TfI mRNA sequence but also shares 19/21-bp identity with Coup-TfII. b, photographic images of
C2C12 PMBs and differentiated myotubes in stable C2C12 pSilencer negative 3.1 control and pSilencer 3.1 Coup-Tf-siRNA. c and d, Coup-TfI and Coup-TfII
attenuation in C2C12 stable siRNA cell lines, respectively. -Fold changes of Coup-TfI and Coup-TfII are expressed relative to both Gapdh and 18 S rRNA. e, -fold
change inGapdh expression relative to 18 S rRNA. f and g, Western blot analysis of Coup-TfI, II, andGapdh in the C2C12 stable expressing pSilencer negative 3.1
control and pSilencer 3.1 Coup-Tf-siRNA. COUP-TfI (46 kDa), COUP-TfII (45.5 kDa), and GAPDH (37 kDa) shown at their approximatemolecularmasses were
used as a loading control. h, expression of both Coup-TfI and II in transient pSilencer 3.1 negative control and Coup-Tf-siRNA expressing C2C12 cell lines. For all
experiments, the mean  S.D. were derived from three independent RNA preparations (each analyzed in triplicate). Significance was calculated using the
Student’s t test; *, p 0.01–0.05 and ***, p 0.0001.
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Coup-Tf-siRNA (36 mol/liter) relative to the negative 3.1
control cells (7 mol/liter) (Fig. 5c).
Repression of the Coup-Tfs Attenuates the Expression of Genes
Involved in Reverse Cholesterol Transport (Abca1 and Abcg1)—
We further analyzed a number of important genes implicated in
lipid efflux.We observed themRNAs
encoding the reverse cholesterol
transporters, Abca1 and Abcg1,
were both significantly attenuated
(4.5-fold, p  0.0073, and 3.86-fold,
p  0.0063, respectively) (Fig. 5, d
and e).
The Effects of Coup-Tf Repression
on Lipid Homeostasis Are Independ-
ent of Differentiation—To evaluate
whether the changes observed in the
Coup-Tf-siRNA stable cell lines were
not due to aberrant differentiation,
the mRNA levels of the differentia-
tion (myogenin) and contractile
(Tnni1 andTnni2)markerswere ana-
lyzed in the RNA samples derived
from both the differentiated negative
controls and the Coup-Tf-siRNA sta-
ble cell lines.Minimal non-significant
changes in the expression of the
mRNA encoding myogenin and tro-
ponin I were observed when com-
pared with the negative 3.1 control
(Table 3) relative to the dramatic sig-
nificant changes observed in themet-
abolic genes reported above. More-
over, and more importantly, we observed both induction (e.g.
Ucp3, Fig. 5b) and repression (e.g. Cpt-1 and Abca1, Figs. 4b and
5d, respectively) of genes in the stable cells that are inducedduring
the normal differentiation process (Fig. 2, d, f, and h). These data
emphasize that the observedphenomenonarenot differentiation-
dependent and further validate that the modulating effects of
Coup-Tf attenuation on metabolism were not due to aberrant
differentiation.
Furthermore, to establish that the attenuation of Coup-Tf
and the modulation of core metabolic genes was not an artifact
of the G148 selection process, we performed Q-RT-PCR on
these key genes from cells transiently transfected with the
Coup-Tf-siRNA. In these studies we observed identical modu-
lation of these key genes (for example, Ppar,Abca1,Ucp3, and
Cpt-1 (supplementary materials Fig. S1, a–d) suggesting the
effects observed in theCoup-Tf-siRNAcells was not inherent to
the stable C2C12 cell lines.
Repression of Coup-TfI and II Compromises LXR-mediated
Activation of Abca1, Abcg1, and Srebp-1c mRNA Expression—
We observed that suppression of Coup-TfI and II mRNA
expression attenuated the expression of several “classical” Lxr
target genes including Abca1, Abcg1, and Srebp-1c. Therefore,
we explored the potential cross-talk between Coup-Tf and Lxr
signaling in skeletal muscle cells and examined the effect of
attenuatedCoup-Tf expression on Lxr signaling. Consequently,
we treated the negative control and the Coup-Tf-siRNA-trans-
fected stable C2C12 cell lines with vehicle (Me2SO), and the
potent/selective LXR agonist, T0901317, and examined the
activation of several classical LXR target genes. T0901317 treat-
ment of the negative control cells resulted in a robust activation
of the LXR target genes Abca1, Abcg1, and Srebp-1c (approxi-
FIGURE4.Coup-Tf siRNAexpression suppressespathways involved in lipidutilization.a, Fabp3;b,Cpt-1; c,
palmitate oxidation;d,Ppar; e, Il-15; and f,Pepck-1. -Fold changes of geneexpression are relative toGapdh. For
all experiments, the mean S.D. were derived from three independent RNA preparations (each analyzed in
triplicate). c, total nanomoles of 3H2O/hproduced throughoxidationof [
3H]palmitic acidwas calculated from
n 9 experiments according to a standard curve generated using increasing concentrations of [3H]palmitic
acid. pSilencer negative 3.1 controls (7.24 0.51) and Coup-Tf-siRNA (5.38 0.32) stable C2C12 cells. Signifi-
cance was calculated using the Student’s t test, where *, p  0.01–0.05; **, p  0.001–0.01; and
***, p 0.0001. Note: Pecpk-1was undetectable in the pSilencer 3.1 Coup-Tf-siRNA stable cell lines.
TABLE 1
Relative expression of genes involved in energy expenditure and
glucose/lipid metabolism
Gene Relative expressionC2C12 negativea
Relative expression
C2C12 siRNAa
-Fold change
and p valueb
Energy expenditure and balance
Ucp2 10132 2622 3972 15.7 2.55 p 0.0785
Ampk3 57210 5992 28310 1148 2.0 p 0.0087
Ampk2 22690 2758 15100 2013 1.5 p 0.0903
Ampk2 15050 1721 7236 1486 2.0 p 0.0429
Ampk2 5586 1176 5497 639.4 1.0 p 0.9454
Fatty acid homeostasis
Cd36 1974 375.3 920.2 200.2 2.1 p 0.0685
Fabp4 66.45 17.68 49.10 17.89 1.35 p 0.5585
Acs4 4383 332.4 2125 242.3 2.0 p 0.0050
Lpl 12670 1211 12080 1352 1.0 p 0.7618
Mcad 4636 156 2721 333.2 1.7 p 0.0065
ApoE 4242 1097 2825 224 1.5 p 0.2743
Fas 3564 281 1716 409.9 2.0 p 0.0199
Scd-1 90530 1884 54520 54520 1.6 p 0.0011
Scd-2 52472 1735 47637 1156 1.1 p 0.1373
Srebp1c 1019 74 360.9 71.95 2.8 p 0.0237
Lipe 10892 520.9 4796 393.5 2.3 p 0.0007
Glucose homeostasis
Glut 4 0.5232 0.109 0.4819 0.0614 1.0 p 0.7856
Glut 5 2469 292.4 3644 184.1 1.5 p 0.0356
Pygm 97850 13663 119388 9549 1.2 p 0.0347
Glycogexin 16.52 1.16 23.42 2.533 1.4 p 0.1318
Pdk-2 2063 218.2 1867 109.4 1.1 p 0.4610
Pdk-4 832.7 87.7 424.9 67.31 1.9 p 0.0210
a Relative expression expressed as number of transcripts per GAPDH transcript 
S.D.
b -Fold change and associated p value.
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mately, 30-, 7-, and 3.8-fold, respectively, relative to the vehicle,
Fig. 6, a–c), and as reported previously (20). In contrast, the
repression ofCoup-Tf attenuated the Lxr-mediated/dependent
transactivation of Abca1, Abcg1, and Srebp-1c (Fig. 6, a–c,
respectively). These effects occurred in the absence of any sig-
nificant changes in Lxr and LxrmRNA expression (Fig. 6, d
and e).
It has been well documented that activation of Lxr-depend-
ent Abca1 and Abcg1 expression increases reverse cholesterol
transport, and reduces intracellular cholesterol levels. In this
context we had observed an ablation of the Lxr-dependent acti-
vation of Abca1 and Abcg1 mRNA expression. Therefore, we
analyzed the effect of the selective LXR agonist, T0901317, on
total intracellular cholesterol levels in the negative control
and the Coup-Tf-siRNA-transfected cells. As expected, we
observed a significant reduction in total intracellular choles-
terol in negative control cells. In contrast, the LXR agonist did
not reduce intracellular cholesterol levels in the Coup-Tf-
siRNA-transfected cell lines (Fig. 7, a and b). This correlates
with the attenuated induction of Abca1 and Abcg1 mRNA
expression after T0901317 treatment in the Coup-Tf-siRNA-
transfected cell line.
Repression of Coup-TfI and II mRNA Expression Ablates
the Lxr-mediated Activation of the ABCA1 Promoter—Fi-
nally, we examined whether the attenuation of Coup-Tf
affected the activity of the ABCA1 promoter. T0901317
treatment relative to vehicle increased the activity of the
Lxr-dependent ABCA1 promoter in the negative control
cells. In contrast, T0901317 treatment (relative to vehicle)
did not activate the ABCA1 promoter in the Coup-Tf-
siRNA-transfected stable cells (Fig. 7c). This suggested the
effects of Coup-Tfs on ABCA1 expression are mediated by
transcriptional mechanisms.
DISCUSSION
COUP-TFs are members of the orphan nuclear receptor
superfamily that are implicated in neurogenesis and organo-
genesis. Sporadic reports suggested COUP-TFs regulate sev-
eral genes involved in cholesterol homeostasis, fatty acid oxi-
dation, and ketogenesis. However, the functional role of
COUP-TFs with respect to the control of genetic programs
associated with metabolism in skeletal muscle (or any other
major mass peripheral tissue) has not been addressed. Here,
we have utilized siRNA-mediated targeting of Coup-TfI and
II to investigate whether the Coup-Tfs regulate critical path-
ways of metabolism in C2C12 skeletal muscle cells. We uti-
lized the mouse C2C12 skeletal muscle cell culture model as
previous data derived from this in vitromodel with LXR and
PPAR agonists (20) were verified/validated in subsequent
in vivo mouse studies (24, 25).
The Coup-TfI and II mRNAs are constitutively expressed
during C2C12 skeletal muscle myogenesis. In contrast,
Coup-Tf protein levels are down-regulated as the C2C12s exit
the cell cycle and undergo myogenic differentiation. This sug-
gests that during differentiation, and/or cell cycle withdrawal
that Coup-Tf is regulated by translational control mechanisms.
Whether this involves mechanisms targeting the 5 and 3
untranslated regions and/or subcellular localization is not cur-
rently known. However, sea urchin homologs of Coup-TfI are
stored as maternal RNA in the egg, a common site of transla-
tional regulation (26).
Stable expression of the Coup-Tf-siRNA (relative to the
pSilencer 3.1 negative control) in the C2C12 skeletal muscle
cells significantly attenuated both Coup-TfI and II mRNA (5-
and 4.75-fold, respectively) relative to two controls,Gapdh and
18 S rRNA. Moreover, these effects were independent of the
differentiation status of the C2C12 cells.
Our study demonstrates that a subgroup of genes (including,
Fabp3, Cpt-1, and Ppar) involved in intramyocellular lipid
mobilization/utilization and catabolism are dependent on the
expression of Coup-Tfs. This is further highlighted by the fact
that related genes such as Fabp4, Ppar /, and Ppar (and
genes in similar pathways for example, Mcad, Lpl, and several
other NRs) were refractory to the attenuation of Coup-Tf
expression (see Tables 1–3). The observed reduction of these
key metabolic target genes is noteworthy for a number of rea-
sons. First, correlation between Fabp3 and Ppar expression
has been described during transcriptional adaptation of lipid
homeostasis in the skeletalmuscle of endurance trained human
males (27). Second, the attenuated expression of Cpt-1 corre-
lates with reduced Ppar expression. Cpt-1 is a well character-
izedPpar (and ) target gene (28). The roles of the above genes
as important regulators of the lipolytic mobilization and catab-
olismof fatty acids (Ppar (29),Fabp3 (30), andCpt-1 (30)), and
their modulation in our C2C12 cell line with attenuated Coup-
TfI and II expression, suggests thatCoup-Tfs plays a critical role
in modulating lipolysis in this system. This is underscored by
reduced pamitate/-oxidation in the Coup-Tf-siRNA-trans-
fected cells.
The role of the COUP-TFs in lipid utilization may appear
contrary to the differentiation dependent regulation ofCoup-Tf
in the cell culture model. However, the Coup-Tfs are abun-
dantly expressed in skeletal muscle tissue (4). Second, it is per-
tinent to point out that Ppar was described as a regulator of
lipid storage that mediated the actions of insulin sensitizers in
adipose tissue. Later studies with muscle-specific Ppar null
mice underscored the role of this NR in skeletal muscle in the
TABLE 2
Relative expression of members of the nuclear receptor superfamily
and inflammatory factors
Gene Relative expressionC2C12 negativea
Relative expression
C2C12 xiRNAa
-Fold change
and p valueb
Nuclear receptors
Err 3.044 0.521 1.691 0.343 1.8 p 0.1624
Err 509.3 103 286.1 32 1.78 p 0.1085
Lxr 109.4 15.40 44.13 1.284 2.5 p 0.0134
Lxr 3072 133.6 2045 176.6 1.5 p 0.0098
Ppar/ 1917 94.20 1004 104.4 1.9 p 0.0012
Ppar 882.1 81.33 323.3 23.54 2.7 p 0.0027
Rev-erb 9319 1610 7456 770 1.2 p 0.3178
Rev-erb 21645 1508 7790 965.8 2.8 p 0.0015
Ror 91.07 3.638 76.06 9.580 1.2 p 0.2169
Ror 2199 282.9 1760 421.5 1.2 p 0.4779
Nurr1 7983 271.6 8483 1486 1.06 p 0.7572
Nur77 1843 361.9 2237 227.8 1.2 p 0.4090
Inflammatory mediators
Il-6 2482 177.5 2838 148 1.0 p 0.1990
Ib 212500 15080 159700 15210 1.3 p 0.0695
Nf-p65 330500 32320 201100 39470 1.6 p 0.0642
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context of insulin sensitivity, despite weak expression in this
lean tissue (31).
The observed attenuation of Il-15 in theCoup-Tf-siRNAwas
interesting. Il-15 (and several other cytokines Il-6 and -8 (32,
33)) are expressed in skeletal muscle tissue andC2C12 cells and
inducedduringmyogenesis (34). Furthermore, it has beendem-
onstrated that IL-15 has an anabolic effect of skeletal muscle in
vitro and in vivo (33). In contrast, adipogenic cells do not
express Il-15. Moreover, IL-15 administered to rodents
decreased white adipose tissue mass and induced adiponectin
secretion (23). In fact, recent studies have suggested that Il-15
functions in a muscle-to-fat endocrine axis to reciprocally reg-
ulate muscle/adipose tissue mass and to control insulin sensi-
tivity (23). The repression of Il-15 in the Coup-Tf-siRNA cell
line provides further support for a critical regulatory role of this
orphan NR in metabolism. Moreover, the link between Coup-
Tfs and Il-15 in muscle, and the role of Il-15 in the muscle/fat
axis and insulin sensitivity correlates with the effects of the
pancreatic Coup-TfII “knock-out” on glucose intolerance (11).
The attenuation of the Pepck-1 mRNA in the Coup-Tf-siRNA
cells is consistent with previous studies demonstrating
Coup-TfII-dependent induction of Pepck-1 transcription by
glucocorticoids (2, 35).
We report that the attenuation of Coup-TfI and II in C2C12
cells modulates key genes involved in lipid utilization. Specifi-
cally, we observed that the mRNA encoding uncoupling pro-
teins 1 and 3 (Ucp1 andUcp3) were significantly repressed and
activated, respectively, in the Coup-Tf-siRNA stable cells. In
this context the C2C12 Coup-Tf-siRNA cells expressed signifi-
cantly elevated steady state levels of total ATP (5-fold) rela-
tive to the negative 3.1 control cells. Thismay correlatewith the
reduction ofUcp1mRNA expression in these cells. Along these
lines ectopic overexpression of Ucp1 in HepG2 cells demon-
strated a 23% reduction in ATP steady state levels (36). We
should note thatUcp1 is almost exclusively expressed in brown
adipose tissue. However, studies have reported Ucp1 mRNA
expression is induced during myogenesis in C2C12 skeletal
muscle cells (22, 37) and demonstrated thatUcp1 expression in
muscle increases in a pathophysiological context. For example,
Ucp1 is up-regulated in the soleus of the kyphoscoliosis (ky)
0123
FIGURE 5. Attenuation of Coup-Tf expression affects expression of the
uncoupling genes and the reverse cholesterol transporter genes (Abca1
and Abcg1). a, Ucp1; b, Ucp3; and c, total ATP production. The Coup-Tf-siRNA
produced an approximate 5-fold increase in total ATP (36 mol/liter, p 
0.0002) relative to the pSilencer 3.1 negative control (7 mol/liter) (c). d,
Abca1; e, Abcg1. -Fold changes of gene expression are relative to Gapdh.
Mean  S.D. was derived from three independent RNA preparations (each
analyzed in triplicate). Significance was calculated using the Student’s t test;
***, p  0.0001. Note: Ucp1 was undetectable in the Coup-Tf-siRNA stable
C2C12 cell lines (a).
TABLE 3
Minimal effect on biochemical markers of differentiation, myogenin,
TNNI1, and TNNI2
Muscle-specific genes
Myogenin 98.42 2.506 240.2 36.89a 2.4 p 0.0144b
Tnni1 50362 3873 52274 9260 1.0 p 0.8576
Tnni2 3039 461.2 1578 79.26 1.9 p 0.0355
a Relative expression expressed as number of transcripts per GAPDH transcript 
S.D.
b -Fold change and associated p value.
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mouse mutant (38), a strain with muscular dystrophy localized
to type I muscle fibers.
Ucp3 is highly expressed in skeletal muscle, in contrast to the
role of Ucp1 in -oxidation associated energy expenditure; the
role of theUcp3 is less understood. Ectopic and overexpression
of Ucp3 in transgenic mice and in cell culture (39–43) suggest
thatUcp3 is involved in adiposity, and preferential lipid utiliza-
tion. Our study indicates that repression of Coup-Tfs leads to a
significant increase in Ucp3 mRNA expression. Although, a
paradoxical observation in the context of reduced palmitate
oxidation, Fabp3, Cpt-1, and Ppar expression; induction of
Ucp3 has been reported as a compensatory response to the
attenuation of Ucp1 expression in a non-obese Ucp1 null mice
model (44). From this perspective,Ucp3may be implicated in a
more protective role in the mitochondria against lipid-induced
oxidative damage. Second, the expression of theUcp3 (a Ppar
target gene) is surprisingly maintained in the skeletal muscle of
Ppar null mice (45). These reports are in concordance with
our observations.
The observed significant repression of classical LXR target
genes involved in reverse cholesterol efflux and lipogenesis
(Abca1, Abcg1, and Srebp-1c etc.) in the Coup-Tf-siRNA-trans-
fected cells is of interest for several reasons. First,Coup-TfII has
been demonstrated to activate the cholesterol 7-hydroxylase
(CYP7A1) (6, 46), and the cholesterol ester transfer protein
(CETP) gene promoters (8), important genes in cholesterol
homeostasis. Second, the Cyp7a1 and Cetp genes have also
been demonstrated to be directly trans-activated by LXR ago-
nists (47, 48). Indeed, studies of Lxr/ null mice failed to
induce the expression of the Cyp7a1 (49), which has also been
demonstrated to be dependent on Coup-Tf expression (6, 46,
50, 51). This suggested to us the existence of cross-talk between
and Lxr and Coup-Tf signaling in muscle. In concordance with
this hypothesis we clearly observed that repression of the
Coup-Tfs significantly diminished the classical and very
reproducible activation of Abca1 (mRNA and promoter),
Abcg1, and Srebp-1cmRNA (20, 52) expression by the selec-
tive LXR agonist, T0901317, independent of major changes
in Lxr and Lxr expression. Moreover, this was consistent
with no change in intracellular cholesterol levels in the
Coup-Tf-siRNA cell line (in contrast to the negative control)
after treatment with the LXR agonist (T0901317). In
humans, mutations in the ABCA1 gene have been linked to
Tangier disease, where these patients have a decreased abil-
ity to efflux cholesterol and consequently accumulate cellu-
lar cholesterol (53). Recently, it has been shown that a
Ppar-Rxr-Lxr axis in mouse liver modulates an overlapping
set of genes involved in both fatty acid catabolism and syn-
thesis (54). This may also be true in our C2C12 cell model
FIGURE 6. Coup-Tf-siRNA expression represses Lxr-mediated activation
of Abca1, Abcg1, and Srebp-1c. C2C12 differentiated myotubes were
treated with vehicle (Me2SO) or 10 mol/liter of the LXR agonist, T0901317,
for 24 h. Total RNA was extracted and Q-RT-PCR was performed. a–e, Abca1,
Abcg1, Srebp-1c, Lxr, and Lxr mRNA expression, respectively, in the pSi-
lencer 3.1 negative control and the Coup-Tf-siRNA.Mean S.D. of three inde-
pendent stable cell preparations are shown. Significance was calculated
using the Student’s t test, where *, 0.01–0.05; **, 0.001–0.01; and ***, p
0.0001. N.S. indicates not significant. Note: for each experiment in the nega-
tive control and the Coup-Tf-siRNA, the Me2SO vehicle was set at 1.
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whereby the ablation of Coup-Tf and subsequent Ppar
attenuation results in the modulation of LXR-dependent
genes involved in metabolism.
A number of studies have demonstrated a role for Coup-Tfs
in cholesterol metabolism. For example, Coup-TfII was shown
to abrogate the transactivation of reporter constructs contain-
ing the ApoA-II, ApoB, and ApoC-III gene promoters (55).
These proteins are major components of the high density
lipoproteins and are critical for their role in transporting cho-
lesterol from extrahepatic tissues to the liver for processing and
excretion in the form of bile acids. Moreover, they are intrinsi-
cally linkedwith the pathogenesis of atherosclerosis. The ability
ofCoup-Tf tomodulateLxr-inducible gene expression involved
in cholesterol homeostasis may have utility in the future (if
novel small molecule regulators are identified) in the context of
cholesterol homeostasis.
In summary, these links between theCoup-Tfs, Lxr, and cho-
lesterol efflux in skeletal muscle are consistent with other stud-
ies on Coup-Tf- and Lxr-mediated gene regulation and choles-
terol homeostasis in several other major mass tissues.
Moreover, these studies underscore the role of Coup-Tfs in
skeletal muscle lipid utilization andmobilization, and provide a
robust system to further study the molecular mechanisms
involved in Coup-Tf/Lxr-dependent control of cholesterol
homeostasis. Further studies are underway to examine the role
of these orphan NRs in tissue-specific animal models.
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Supplementary Figure 1.
a).                                         b).                                              c).                                         d).                                  
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Supplementary Figure 1: Transient transfection of COUP-TF-siRNA in C2C12 cells invokes similar
responses to those observed in the stable C2C12 COUP-TF-siRNA cells.  To establish that the modulation 
of key genes in the C2C12 stable COUP-TF-siRNA cells was not an artifact of the G418 selection process, 
Q-RT-PCR was performed on a number of these genes from transient studies. a. PPAR alpha, b. ABCA1,
c. UCP3, and d. CPT-1.  Fold changes of gene expression are relative to GAPDH. The mean +/- S.D of three 
independent cell preperations are shown.  Significance was calculated using the Student’s t-test where * p =
0.01-0.05, ** p = 0.001-0.01 and *** p < 0.0001.
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